This HTML5 document contains 71 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n13http://tracerx.co.uk/studies/melanoma/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n6https://global.dbpedia.org/id/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
n15https://orcid.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n16http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Samra_Turajlic
rdf:type
dbo:Species owl:Thing wikidata:Q215627 dbo:Animal wikidata:Q901 n16:NaturalPerson schema:Person wikidata:Q5 foaf:Person dbo:Scientist wikidata:Q19088 dbo:Person dbo:Eukaryote wikidata:Q729
rdfs:label
Samra Turajlic
rdfs:comment
Samra Turajlic is a medical oncologist and cancer researcher. She leads the cancer dynamics lab at the Francis Crick Institute in London, which focuses on understanding how cancers evolve, as well as working as an oncologist at the Royal Marsden. Her work has revealed that kidney cancers follow a set number of evolutionary paths, each with its own set of genetic changes. This discovery could help to distinguish between aggressive cancers that require treatment and more benign tumours that can be monitored.
foaf:name
Dr Samra Turajlic
dbp:name
Dr Samra Turajlic
dcterms:subject
dbc:Year_of_birth_missing_(living_people) dbc:Living_people dbc:Cancer_researchers dbc:Alumni_of_the_University_of_Oxford dbc:Academics_of_the_Francis_Crick_Institute dbc:Date_of_birth_missing_(living_people)
dbo:wikiPageID
65390827
dbo:wikiPageRevisionID
1059610818
dbo:wikiPageWikiLink
dbr:Marston_Lineham dbc:Year_of_birth_missing_(living_people) dbr:Cell_Journal dbr:Macmillan_Cancer_Support dbr:Charles_Swanton dbr:Von_Hippel–Lindau_disease dbc:Living_people dbc:Cancer_researchers dbr:University_of_Oxford dbr:Richard_Marais dbr:The_Royal_Marsden_NHS_Foundation_Trust dbr:UCL_Medical_School dbr:Francis_Crick_Institute dbr:Institute_of_Cancer_Research dbc:Date_of_birth_missing_(living_people) dbr:National_Institutes_of_Health dbr:Cancer_Research_UK dbc:Academics_of_the_Francis_Crick_Institute dbc:Alumni_of_the_University_of_Oxford
dbo:wikiPageExternalLink
n13:
owl:sameAs
n6:FPBwy wikidata:Q98177175 n15:0000-0001-8846-136X
dbp:thesisYear
2003
dbp:workplaces
the Francis Crick Institute Royal Marsden NHS Foundation Trust
dbp:wikiPageUsesTemplate
dbt:Short_description dbt:Infobox_scientist dbt:Reflist dbt:Authority_control dbt:Improve_categories
dbp:almaMater
University of Oxford Institute of Cancer Research UCL Medical School
dbp:fields
Cancer evolution, kidney cancer, melanoma
dbo:abstract
Samra Turajlic is a medical oncologist and cancer researcher. She leads the cancer dynamics lab at the Francis Crick Institute in London, which focuses on understanding how cancers evolve, as well as working as an oncologist at the Royal Marsden. Her work has revealed that kidney cancers follow a set number of evolutionary paths, each with its own set of genetic changes. This discovery could help to distinguish between aggressive cancers that require treatment and more benign tumours that can be monitored.
dbp:academicAdvisors
Charles Swanton
dbp:doctoralAdvisor
Richard Marais
dbo:academicAdvisor
dbr:Charles_Swanton
dbo:doctoralAdvisor
dbr:Richard_Marais
prov:wasDerivedFrom
wikipedia-en:Samra_Turajlic?oldid=1059610818&ns=0
dbo:wikiPageLength
9754
dbo:almaMater
dbr:UCL_Medical_School dbr:Institute_of_Cancer_Research
foaf:isPrimaryTopicOf
wikipedia-en:Samra_Turajlic